Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Target for new lung cancer therapy found in embryonic cell pathway

06.03.2003


New work by researchers in the Kimmel Cancer Center at Johns Hopkins may allow them to halt the smoking-induced cellular events that lead to 99 percent of all small cell lung cancers (SCLC). The research is reported in the March 5, 2003, issue of Nature.



The researchers found that a primitive cellular pathway, called Sonic Hedgehog (named for the cartoon character and spiky hairs it develops on fruit flies) stays turned on long after it should be turned off in some lung cancers.

"We believe chronic injury to the lungs by cigarette smoking re-activates genes in the Hedgehog pathway to repair cell damage in the lining of the lungs. The ongoing and regular assault to the lungs by cigarettes causes the usually dormant pathway to be stuck in activation mode making too many new cells, ultimately resulting in cancer," says Neil Watkins, Ph.D., research associate at the Kimmel Cancer Center and lead author of the study.


The Sonic Hedgehog pathway has been well studied for its role in the development of mammalian embryonic cells, and more recently, for its relationship to cancer. Now, Kimmel Cancer Center investigators are testing drugs on mice, including one called cyclopamine, that block the Hedgehog pathway. Human clinical trials are not planned at this time and may be three to four years away.

The scientists analyzed tissue samples and tumor cell lines from SCLC and non-small cell lung cancer (NSCLC) patients. Of ten SCLC tissue samples studied, half showed activation of the Hedgehog pathway and increased expression of one of its targets called the Gli1 gene. They confirmed these findings by looking at SCLC cell lines in which five of seven lines examined showed similar activation of the Hedgehog pathway and Gli1 gene. Limited activation of the pathway was found in NSCLC.

"This study represents one of the first attempts to therapeutically manipulate this cell pathway, and it’s a perfect example of how basic developmental science can have clinical implications in a relatively short period of time," says Stephen B. Baylin, M.D., Ludwig professor of oncology and director of research at the Kimmel Cancer Center.

Lung cancer is the leading cancer killer. Close to 172,000 cases are diagnosed each year. Unresponsive to standard therapy, SCLC is the most lethal form of lung cancer. It typically cannot be treated with surgery and though it initially responds to chemotherapy, most patients relapse. "As cigarette smoking persists among young people, we expect to be dealing with this disease for years to come. As a result, the search for potential new therapies are key to controlling this disease," says Watkins.

In addition to Watkins and Baylin, other Johns Hopkins participants in this research include David Berman, Scott G. Burkholder, Baolin Wang, and Philip Beachy.



The research was funded by the Flight Attendant Medical Research Institute and a National Cancer Institute lung cancer SPORE (Specialized Projects of Research Excellence).

Under a licensing agreement between the Johns Hopkins University and Curis, Inc., Dr. Beachy is entitled to a share of royalty received by the University from sales of products related to the research described in this press release. The University and Dr. Beachy own Curis, Inc. stock, the sale of which is subject to certain restrictions. The terms of this arrangement are being managed by the University in accordance with its conflict of interest policies.

Media Contact: Vanessa Wasta 410-955-1287
Email: wastava@jhmi.edu

Vanessa Wasta | EurekAlert!
Further information:
http://www.hopkinskimmelcancercenter.org

More articles from Health and Medicine:

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

nachricht Flexible sensors can detect movement in GI tract
11.10.2017 | Massachusetts Institute of Technology

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Ocean atmosphere rife with microbes

17.10.2017 | Life Sciences

Neutrons observe vitamin B6-dependent enzyme activity useful for drug development

17.10.2017 | Life Sciences

NASA finds newly formed tropical storm lan over open waters

17.10.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>